Drug intelligence / Profile preview

p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate is a synthetic dinucleotide analog in which adenosine and thymidine are connected via a pentaphosphate bridge through their 5' positions. It is an experimental small molecule designed as a bisubstrate inhibitor of thymidylate kinase (TMPK), an enzyme involved in nucleotide metabolism. Structural studies have shown that it binds to the active site of TMPK and can serve as a tool compound for probing enzyme mechanism or for structure-based drug design targeting TMPK—an essential enzyme in DNA synthesis pathways of bacteria such as Mycobacterium tuberculosis[7]. The compound has not been approved for clinical use and is primarily used in biochemical research[2][7].

Other names
p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl [hydroxy-[hydroxy-[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxyphosphoryl]oxyphosphoryl] hydrogen phosphate
02

Targets

TMPK (Thymidine monophosphate kinase (Mycobacterium tuberculosis))

Beyond the preview

Go deeper on p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call